Minas T, Nehrer S
Department of Orthopedics, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA.
Orthopedics. 1997 Jun;20(6):525-38. doi: 10.3928/0147-7447-19970601-08.
Over time, articular cartilage loses the capacity to regenerate itself, making repair of articular surfaces difficult. Lavage and debridement may offer temporary relief of pain for up to 4.5 years, but offer no prospect of long-term cure. Likewise, marrow-stimulation techniques such as drilling, microfracture, or abrasion arthroplasty fail to yield long-term solutions because they typically promote the development of fibrocartilage. Fibrocartilage lacks the durability and many of the mechanical properties of the hyaline cartilage that normally covers articular surfaces. Repair tissue resembling hyaline cartilage can be induced to fill in articular defects by using perichondrial and periosteal grafts. However, these techniques are limited by the amount of tissue available for grafting and the tendency toward ossification of the repair tissue. Autogenous osteochondral arthroscopically implanted grafts (mosaicplasty), or open implantation of lateral patellar facet (Outerbridge technique), requires violation of subchondral bone. Osteochondral allografts risk viral transmission of disease and low chondrocyte viability, in addition to removal of host bone for implantation. Autologous chondrocyte implantation offers the opportunity to achieve biologic repair, enabling the surgeon to repair the joint surface with autologous articular cartilage. With this technique, care must be taken to ensure the safety, viability, and microbial integrity of the autologous cells while they are expanded in culture over a 4- to 5-week period prior to implantation. Surgical implantation requires equal attention to meticulous technique. In the future, physiologic repair also may become possible using mesenchymal stem cells or chondrocytes delivered surgically in an ex vivo-derived matrix. This would allow in vitro manipulation of cells with growth factors, mechanical stimuli, and matrix sizing to allow implantation of mature biosynthetic grafts which would allow treatment of larger defects with decreased rehabilitation and morbidity.
随着时间的推移,关节软骨会丧失自我再生能力,导致关节表面修复困难。灌洗和清创术可能会在长达4.5年的时间内暂时缓解疼痛,但无法实现长期治愈。同样,诸如钻孔、微骨折或磨削关节成形术等骨髓刺激技术也无法提供长期解决方案,因为它们通常会促进纤维软骨的形成。纤维软骨缺乏通常覆盖关节表面的透明软骨的耐久性和许多力学性能。通过使用软骨膜和骨膜移植物,可以诱导类似透明软骨的修复组织填充关节缺损。然而,这些技术受到可用于移植的组织量以及修复组织骨化倾向的限制。自体骨软骨关节镜下植入移植物(镶嵌成形术)或外侧髌骨关节面开放植入(奥特尔布里奇技术)需要破坏软骨下骨。异体骨软骨移植除了需要去除宿主骨进行植入外,还存在疾病病毒传播和软骨细胞存活率低的风险。自体软骨细胞植入提供了实现生物修复的机会,使外科医生能够用自体关节软骨修复关节表面。使用这种技术时,在植入前4至5周的培养过程中,必须注意确保自体细胞的安全性、活力和微生物完整性。手术植入同样需要注重精细技术。未来,使用间充质干细胞或软骨细胞通过手术植入体外衍生基质进行生理修复也可能成为现实。这将允许在体外利用生长因子、机械刺激和基质尺寸对细胞进行操作,从而植入成熟的生物合成移植物,进而能够治疗更大的缺损,同时减少康复时间和发病率。